A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial

STUDY QUESTION: Can increasing the duration of LH-exposure with a second dose of kisspeptin-54 improve oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS)? SUMMARY ANSWER: A second dose of kisspeptin-54 at 10 h following the first improves oocyte yield in women at hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbara, Ali, Clarke, Sophie, Islam, Rumana, Prague, Julia K, Comninos, Alexander N, Narayanaswamy, Shakunthala, Papadopoulou, Deborah, Roberts, Rachel, Izzi-Engbeaya, Chioma, Ratnasabapathy, Risheka, Nesbitt, Alexander, Vimalesvaran, Sunitha, Salim, Rehan, Lavery, Stuart A, Bloom, Stephen R, Huson, Les, Trew, Geoffrey H, Dhillo, Waljit S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850304/
https://www.ncbi.nlm.nih.gov/pubmed/28854728
http://dx.doi.org/10.1093/humrep/dex253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850304/
https://www.ncbi.nlm.nih.gov/pubmed/28854728
http://dx.doi.org/10.1093/humrep/dex253

Ejemplares similares